Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Lung carcinoma morphology or mutational profile: that is the question.

Dacic S.

Arch Pathol Lab Med. 2011 Oct;135(10):1242-3. doi: 10.5858/arpa.2011-0223-ED. No abstract available.

PMID:
21970476
2.

Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule.

Nakano H, Soda H, Takasu M, Tomonaga N, Yamaguchi H, Nakatomi K, Fujino S, Hayashi T, Nakamura Y, Tsukamoto K, Kohno S.

Lung Cancer. 2008 Apr;60(1):136-40. Epub 2007 Sep 24.

PMID:
17889960
3.

Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung.

Fukui T, Tsuta K, Furuta K, Watanabe S, Asamura H, Ohe Y, Maeshima AM, Shibata T, Masuda N, Matsuno Y.

Cancer Sci. 2007 Nov;98(11):1714-9. Epub 2007 Sep 2.

4.

[A case of pulmonary pleomorphic carcinoma with epidermal growth factor receptor (EGFR) mutation].

Watanabe K, Ishida T, Fukuhara A, Sekine S, Uekita K, Sugawara A, Tachihara M, Kanazawa K, Saito J, Tanino Y, Munakata M.

Gan To Kagaku Ryoho. 2008 Sep;35(9):1595-7. Japanese.

PMID:
18799919
5.

Pathologist and molecular biologist, ever the twain shall meet?

Kerr KM.

Lung Cancer. 2009 Feb;63(2):161-3. doi: 10.1016/j.lungcan.2008.10.010. Epub 2008 Nov 22. No abstract available.

PMID:
19027983
7.

Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung.

Kang SM, Kang HJ, Shin JH, Kim H, Shin DH, Kim SK, Kim JH, Chung KY, Kim SK, Chang J.

Cancer. 2007 Feb 1;109(3):581-7.

8.

Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.

Cho WC, Chow AS, Au JS.

Eur J Cancer. 2009 Aug;45(12):2197-206. doi: 10.1016/j.ejca.2009.04.039. Epub 2009 Jun 1.

PMID:
19493678
9.

Immunohistochemical detection of mutated epidermal growth factor receptors in pulmonary adenocarcinoma.

Nakamura H, Mochizuki A, Shinmyo T, Ando K, Kurimoto N, Yokote K, Takagi M.

Anticancer Res. 2010 Dec;30(12):5233-7.

PMID:
21187519
10.

Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinoma.

Miyamae Y, Shimizu K, Hirato J, Araki T, Tanaka K, Ogawa H, Kakegawa S, Sugano M, Nakano T, Mitani Y, Kaira K, Takeyoshi I.

Oncol Rep. 2011 Apr;25(4):921-8. doi: 10.3892/or.2011.1182. Epub 2011 Feb 11.

PMID:
21318227
11.

Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma.

Yatabe Y, Matsuo K, Mitsudomi T.

J Clin Oncol. 2011 Aug 1;29(22):2972-7. doi: 10.1200/JCO.2010.33.3906. Epub 2011 Jul 5.

PMID:
21730270
12.

Epidermal growth factor receptor mutations detected in tumors from Chinese "never smokers" with lung adenocarcinoma.

Ren GP, Wang TY, Pan QL, Pao W, Huai J.

Chin Med J (Engl). 2005 May 5;118(9):769-71. No abstract available.

PMID:
15899142
13.

Modern treatment of lung cancer: case 1. Amplification and mutation of the epidermal growth factor receptor in metastatic lung cancer with remission from gefitinib.

Schwab R, Pinter F, Moldavy J, Papay J, Strausz J, Kopper L, Keri G, Pap A, Petak I, Oreskovich K, Mangel L.

J Clin Oncol. 2005 Oct 20;23(30):7736-8. No abstract available.

PMID:
16234532
14.
15.

Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung.

Haneda H, Sasaki H, Shimizu S, Endo K, Suzuki E, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Lung Cancer. 2006 Apr;52(1):47-52. Epub 2006 Feb 28.

PMID:
16503085
16.

A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma.

Haneda H, Sasaki H, Lindeman N, Kawano O, Endo K, Suzuki E, Shimizu S, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Jpn J Clin Oncol. 2006 Feb;36(2):69-75. Epub 2006 Jan 31.

PMID:
16449241
17.

Familial lung adenocarcinoma caused by the EGFR V843I germ-line mutation.

Ohtsuka K, Ohnishi H, Kurai D, Matsushima S, Morishita Y, Shinonaga M, Goto H, Watanabe T.

J Clin Oncol. 2011 Mar 10;29(8):e191-2. doi: 10.1200/JCO.2010.31.4492. Epub 2010 Dec 20. No abstract available.

PMID:
21172876
18.

Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features?

Inamura K, Ninomiya H, Ishikawa Y, Matsubara O.

Arch Pathol Lab Med. 2010 Jan;134(1):66-72. doi: 10.1043/2008-0586-RAR1.1. Review.

PMID:
20073607
19.

Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer.

Ikeda K, Nomori H, Mori T, Sasaki J, Kobayashi T.

Ann Thorac Surg. 2008 Apr;85(4):1430-2. doi: 10.1016/j.athoracsur.2007.10.012.

PMID:
18355544
20.

EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.

Bae NC, Chae MH, Lee MH, Kim KM, Lee EB, Kim CH, Park TI, Han SB, Jheon S, Jung TH, Park JY.

Cancer Genet Cytogenet. 2007 Mar;173(2):107-13.

PMID:
17321325

Supplemental Content

Support Center